Menu
GeneBe

NR0B1

nuclear receptor subfamily 0 group B member 1, the group of Nuclear receptor subfamily 0 group B

Basic information

Region (hg38): X:30304205-30309390

Previous symbols: [ "AHC", "DSS" ]

Links

ENSG00000169297NCBI:190OMIM:300473HGNC:7960Uniprot:P51843AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • X-linked adrenal hypoplasia congenita (Definitive), mode of inheritance: XL
  • 46,XY sex reversal 2 (Moderate), mode of inheritance: XL
  • X-linked adrenal hypoplasia congenita (Definitive), mode of inheritance: XL
  • X-linked adrenal hypoplasia congenita (Supportive), mode of inheritance: XL
  • X-linked adrenal hypoplasia congenita (Strong), mode of inheritance: XL
  • X-linked adrenal hypoplasia congenita (Definitive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Adrenal hypoplasia, congenital; 46,XY sex reversal 2XLEndocrine; Genitourinary; Obstetric; OncologicAffected individuals typically present in infancy with acute-onset adrenal insufficiency, which can be lethal, and preventive and treatment measures can be effectiveEndocrine; Genitourinary; Obstetric; Oncologic6891556; 7951319; 7990958; 9003500; 9529340; 10022408; 11549627; 11788621; 12519885; 17503084; 17164309; 20301604; 20301714; 21408189; 21632081; 21739173; 21925982; 22456342; 22570964
Digenic inheritance (with GNRH1) has been reported; Dosage-sensitive sex reversal has been described due to duplications

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NR0B1 gene.

  • Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 (69 variants)
  • Congenital adrenal hypoplasia, X-linked (50 variants)
  • not provided (42 variants)
  • 46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked (16 variants)
  • Inborn genetic diseases (9 variants)
  • not specified (8 variants)
  • NR0B1-related condition (6 variants)
  • NR0B1-related disorder (1 variants)
  • Mineralocorticoid deficiency, isolated (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NR0B1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
25
clinvar
9
clinvar
34
missense
4
clinvar
5
clinvar
36
clinvar
7
clinvar
6
clinvar
58
nonsense
21
clinvar
2
clinvar
1
clinvar
24
start loss
1
clinvar
1
frameshift
29
clinvar
5
clinvar
34
inframe indel
0
splice donor/acceptor (+/-2bp)
4
clinvar
1
clinvar
5
splice region
1
1
non coding
2
clinvar
2
Total 58 14 37 32 17

Variants in NR0B1

This is a list of pathogenic ClinVar variants found in the NR0B1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-30304336-AT-A Benign (Apr 09, 2019)1278137
X-30304562-GTGTGGCCCACATGACTTTATATCTTTGTACAGAGCATTTCCAGCATCATATCATCCATGCTGACTGTGCCGATGATGGGCCTGAAGAACAGTTCAGCAATGACATTGGCATTGATGAATCTCAGCAGGAAAAGGGTACTATTAAGTTCGATGAATCTGTCATGGGGCCCTTGGTGCGTCATCCTGGTGTGTTCACTGAGTATTTGCTGAGTTCCCCACTGGAGTCCCTGAATGTACTTCACGCACTGCAGGCCCGGCACGTCTGGAGGGAGAAAAATCTCTTTGTTATAAAACAGCTCACCACAGAGTCCTTTGCTAGCTTTTTAAAAATAGCCATTTCTGTTTCATCCCAATTAAACAAGACCCAAAGCTTC-CA Congenital adrenal hypoplasia, X-linked Pathogenic (Oct 17, 2017)444073
X-30304581-A-G Congenital adrenal hypoplasia, X-linked Likely pathogenic (Sep 27, 2016)978419
X-30304582-T-C Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 • NR0B1-related disorder Benign/Likely benign (Jan 19, 2024)1205002
X-30304594-G-C Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Likely benign (Nov 09, 2023)2939716
X-30304615-AT-C Congenital adrenal hypoplasia, X-linked Pathogenic (Oct 01, 1996)10960
X-30304626-CTG-C Congenital adrenal hypoplasia, X-linked Pathogenic (Mar 05, 2009)492859
X-30304627-T-C not specified • Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 • NR0B1-related disorder Benign/Likely benign (Jan 21, 2024)436028
X-30304633-G-A 46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked Benign (Jan 24, 2024)2923653
X-30304638-T-A Uncertain significance (Sep 16, 2018)591253
X-30304638-T-C Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Uncertain significance (Jan 07, 2024)2935250
X-30304641-G-C Inborn genetic diseases Uncertain significance (Nov 21, 2022)2328791
X-30304641-GC-G Congenital adrenal hypoplasia, X-linked Pathogenic (Oct 19, 2020)1806119
X-30304646-A-G Congenital adrenal hypoplasia, X-linked Uncertain significance (Oct 08, 2021)3066153
X-30304652-A-G Congenital adrenal hypoplasia, X-linked Pathogenic (May 18, 2016)492858
X-30304669-G-C Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Likely benign (Mar 19, 2023)1927151
X-30304673-T-A Congenital adrenal hypoplasia, X-linked Pathogenic (Jul 01, 2000)10957
X-30304676-A-C Congenital adrenal hypoplasia, X-linked Pathogenic (Feb 01, 2000)10969
X-30304684-C-T Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Likely benign (Aug 09, 2021)1634697
X-30304690-GA-G Pathogenic (May 20, 2016)279854
X-30304693-A-G Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Likely benign (Aug 16, 2023)2929268
X-30304696-GGTACTATTAA-G Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Pathogenic (Jul 06, 2022)2014691
X-30304699-AC-A Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Pathogenic (Jun 22, 2022)2138497
X-30304711-G-A 46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked Likely benign (Apr 15, 2023)2931279
X-30304713-T-C Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 Likely benign (May 09, 2023)2941449

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NR0B1protein_codingprotein_codingENST00000378970 25393
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9700.0297123291011232920.00000406
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.081501920.7800.00001323013
Missense in Polyphen3058.750.510631073
Synonymous-0.8419988.91.110.00000644986
Loss of Function3.06010.90.006.93e-7165

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00003660.0000366
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity). {ECO:0000250}.;
Disease
DISEASE: Adrenal hypoplasia, congenital (AHC) [MIM:300200]: A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern. {ECO:0000269|PubMed:10323730, ECO:0000269|PubMed:10341858, ECO:0000269|PubMed:10675358, ECO:0000269|PubMed:10848616, ECO:0000269|PubMed:11113848, ECO:0000269|PubMed:11443184, ECO:0000269|PubMed:11748852, ECO:0000269|PubMed:11788621, ECO:0000269|PubMed:12629128, ECO:0000269|PubMed:15800903, ECO:0000269|PubMed:7990958, ECO:0000269|PubMed:9003500, ECO:0000269|PubMed:9063431, ECO:0000269|PubMed:9360549, ECO:0000269|PubMed:9415399, ECO:0000269|PubMed:9529340}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 2 (SRXY2) [MIM:300018]: A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. {ECO:0000269|PubMed:9486644}. Note=The disease is caused by mutations affecting the gene represented in this entry. XY individuals with a duplication of part of the short arm of the X chromosome and an intact SRY gene develop as females. The single X chromosome in these individuals does not undergo X- chromosome inactivation; therefore, these individuals presumably carry 2 active copies of genes, including the NR0B1 gene, in the duplicated region. Individuals with deletion of this region develop as males. Genes within the dosage-sensitive sex reversal region are, therefore, not essential for testis development, but, when present in a double dose, interfere with testis formation.;
Pathway
NHR;Nuclear Receptors;Gene expression (Transcription);Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Validated nuclear estrogen receptor alpha network;Regulation of Androgen receptor activity;Validated nuclear estrogen receptor beta network (Consensus)

Recessive Scores

pRec
0.610

Intolerance Scores

loftool
0.0263
rvis_EVS
-0.49
rvis_percentile_EVS
22.09

Haploinsufficiency Scores

pHI
0.641
hipred
Y
hipred_score
0.511
ghis
0.452

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.787

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nr0b1
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; neoplasm;

Zebrafish Information Network

Gene name
nr0b1
Affected structure
somatic cell
Phenotype tag
abnormal
Phenotype quality
decreased occurrence

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;steroid biosynthetic process;spermatogenesis;protein localization;gonad development;male gonad development;hypothalamus development;pituitary gland development;male sex determination;adrenal gland development;intracellular receptor signaling pathway;negative regulation of intracellular steroid hormone receptor signaling pathway;Leydig cell differentiation;response to immobilization stress;steroid hormone mediated signaling pathway;negative regulation of DNA-binding transcription factor activity;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated;Sertoli cell differentiation
Cellular component
nucleus;nucleoplasm;cytoplasm;microtubule organizing center;membrane;nuclear speck;polysomal ribosome;intracellular membrane-bounded organelle
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;steroid hormone receptor activity;transcription corepressor activity;RNA binding;nuclear receptor activity;protein binding;transcription factor binding;protein domain specific binding;DNA hairpin binding;steroid hormone receptor binding;protein homodimerization activity;sequence-specific DNA binding